{"id":206926,"date":"2025-02-21T07:32:55","date_gmt":"2025-02-21T13:32:55","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/02\/hope-for-ovarian-cancer-new-immunotherapy-target"},"modified":"2025-02-21T07:32:55","modified_gmt":"2025-02-21T13:32:55","slug":"hope-for-ovarian-cancer-new-immunotherapy-target","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/02\/hope-for-ovarian-cancer-new-immunotherapy-target","title":{"rendered":"Hope for ovarian cancer: New immunotherapy target"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/hope-for-ovarian-cancer-new-immunotherapy-target2.jpg\"><\/a><\/p>\n<p>In a study published in <a href=\"https:\/\/www.science.org\/doi\/10.1126\/sciadv.ads7405#:~:text=This%20study%20reveals%20noncoding%20cryptic%20peptides%20as%20an, with%20a%205-year%20survival%20rate%20of%20%3C50%25%20%281%29.\">Scie<\/a><a href=\"https:\/\/www.science.org\/doi\/10.1126\/sciadv.ads7405#:~:text=This%20study%20reveals%20noncoding%20cryptic%20peptides%20as%20an, with%20a%205-year%20survival%20rate%20of%20%3C50%25%20%281%29.\" target=\"_blank\" rel=\"noreferrer noopener\">nce Advances<\/a>, Mayo Clinic researchers found a new immunotherapy target called a cryptic antigen that may be key in helping the immune system fight tumors in <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/ovarian-cancer\/symptoms-causes\/syc-20375941\" target=\"_blank\" rel=\"noreferrer noopener\">ovarian cancer<\/a>.<\/p>\n<p>Cryptic antigens are part of a protein \u2014 known as epitopes \u2014 that are usually hidden or inaccessible to the immune system and may be present in tumor cells.<\/p>\n<p>\u201cThese findings underscore the need to look at alternate sources of target antigens for ovarian cancer,\u201d says <a href=\"https:\/\/www.mayo.edu\/research\/faculty\/curtis-marion-r-ph-d\/bio-20454201\" target=\"_blank\" rel=\"noreferrer noopener\">Marion R. Curtis, Ph.D.<\/a>, a Mayo Clinic senior associate consultant in immunology and senior author of the study.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a study published in Science Advances, Mayo Clinic researchers found a new immunotherapy target called a cryptic antigen that may be key in helping the immune system fight tumors in ovarian cancer. Cryptic antigens are part of a protein \u2014 known as epitopes \u2014 that are usually hidden or inaccessible to the immune system [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-206926","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/206926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=206926"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/206926\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=206926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=206926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=206926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}